This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schachter, M. Search for Related Content PubMed PubMed Citation Articles by Schachter, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

ACE inhibitors, angiotensin receptor antagonists and bradykinin

Department of Clinical Pharmacology and Therapeutics, National Heart and Lung Institute, Imperial College School of Medicine, St Mary's Hospital, London, W2 1NY, UK, m.schachter{at}ic.ac.uk

Key Words: bradykinin • ACE inhibitors • AT1-receptor antagonists • AT2-receptors

References

• Margolius H. Kallikreins and kinins: molecular characteristics and cellular and tissue responses. Diabetes 1996; 45 (suppl 1): S14-S19.
• Zisman LS Inhibiting tissue angiotensin-converting enzyme: a pound of flesh without the blood. Circulation 1998; 98: 2788-2790.[Free Full Text]
• Cleland JG, Morgan K. Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic research. Curr Opin Cardiol 1996; 11: 252-262.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Overlack A. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management. Drug Saf 1996;15: 72-8.[Web of Science][Medline] [Order article via Infotrieve]
• Vleeming W., van Amsterdam JG, Stricker BH, de Wildt DJ ACE inhibitor-induced angioedema: incidence, prevention and management. Drug Saf 1998;18:171-188.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Semple PF Putative mechanisms of cough after treatment with angiotensin-converting enzyme inhibitors.J Hypertens 1995; 13 (suppl 3): S17-S21.[CrossRef][Web of Science]
• Malini PL, Strocchi E., Zanardi M., Milani M.,Ambrosioni E. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997; 350:15-18.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nussberger J., Cugno M., Amstutz C., Cicardi M., Pellacani A., Agostoni A. Plasma bradykinin in angioedema. Lancet 1998; 351: 1693-1697.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dell'Italia LJ, Oparil S. Bardykinin in the heart: friend or foe? Circulation 1999; 100: 2305-2307.[Free Full Text]
• Gohlke P., Pees C., Unger T. AT2-receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31: 349-355.[Abstract/Free Full Text]
• Brown NJ, Ryder D., Gainer JV, Morrow JD, Nadeau J. Differential effects of angiotensin-converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin. J Pharmacol Exp Ther 1996; 279: 703-712.[Abstract/Free Full Text]
• Bönner G. The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors. Drugs 1997; 54 (suppl 5):S23-S30.
• Hornig B., Kohler C., Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997; 95:1115-1118.[Abstract/Free Full Text]
• Gainer JV, Morrow JD, Loveland A., King DJ, Brown NJ Effect of bradykinin-receptor blockade on the response to angiotensin-converting enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998; 339: 1285-1292.[Abstract/Free Full Text]
• Bouaziz H., JoulinY., Safar M., Benetos A. Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition. Br J Pharmacol 1994; 113:717722.
• Cheng CP, Onishi K., Ohte N., Suzuki M., Little WC Functional effects of endogenous bradykinin in congestive heart failure. J Am Coll Cardiol 1998; 31:1679-1686.[Abstract/Free Full Text]
• Su JB, Barbe F., Crozatier B., Campbell B., Campbell DJ, Hittinger L. Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure. J Cardiovasc Pharmacol 1999; 34: 700-710.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Davie AP, Dargie HJ, McMurray JJ Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure. Circulation 1999; 100: 268-273.[Abstract/Free Full Text]
• Yang X-P., Liu Y-H., Scicli GM,Webb CR, Carretero O. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen deficient mice. Hypertension 1997; 30 (part 2): 735-740.[Abstract/Free Full Text]
• Emanueli C., Maetri R., Corradi D. et al. Dilated and failing cardiomyopathy in bradykinin B2 receptor knockout mice. Circulation 1999; 100: 2359-2365.[Abstract/Free Full Text]
• Benzing T., Fleming I., Blaukat A., Müller-Esterl W., Busse R. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells. Circulation 1999; 99: 2034-2040.[Abstract/Free Full Text]
• Chung O., UngerT. Angiotensin II receptor blockade and end-organ protection. Am J Hypertens 1999;12:150S-156S.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kokkonen JO, Sarinen J., Kovanen PT Angiotensin II formation in the human heart: an ACE or non-ACE mediated pathway? Ann Med 1998; 30 (suppl 1): S9-S13. 3.
• Takai S., Jin D., Sakaguchi M., Miyazaki M. Chymase-dependent angiotensin II formation in human vascular tissue. Circulation 1999;100: 654-658.[Abstract/Free Full Text]
• Topol E. ACE inhibitors still the drug of choice for heart failure and more. Lancet 1999; 354: 1797.[Medline] [Order article via Infotrieve]
• Neutel JM Safety and efficacy of angiotensin II receptor antagonists. Am J Cardiol 1999; 84 (suppl 2A): 13K-17K.[Web of Science][Medline] [Order article via Infotrieve]
• Birkenhager WH, de Leeuw PW Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension. J Hypertens 1999; 17: 873-881.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Campbell DJ Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists. Clin Exp Pharmacol Physiol 1996; 3 (suppl): S125-S131.
• Nora EH, Munzenmaier DH, Hansen-Smith FM, Lombard JH, Greene AS Localization of the ANG II type II receptor in the microcirculation of skeletal muscle. Am J Physiol 1998; 275: H1395-H1403.[Web of Science][Medline] [Order article via Infotrieve]
• Yang BC, Phillips MI, Mohuczy D. et al. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998;18:1433-1439.[Abstract/Free Full Text]
• Nakajima M., Hutchinson HG, Fujinaga M. et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1-receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 82: 10663-10667.
• Weber MA Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension. Am J Hypertens 1999;12:189S-194S.[Web of Science][Medline] [Order article via Infotrieve]
• Tsutsumi Y., Matsubara H., Masaki H. et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999;104:925-935.[Web of Science][Medline] [Order article via Infotrieve]
• Searles CD, Harrison DG The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J Clin Invest 1999;104:1013-1014.[Web of Science][Medline] [Order article via Infotrieve]
• Cha YJ, Pearson VE Angioedema due to losartan. Ann Pharmacother 1999; 33: 936-938.[Abstract]
• Mackay FJ, Pearce GL, Mann RD Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol 1999; 47: 111-114.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 1, 27-29 (2000)
DOI: 10.3317/jraas.2000.005


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. I. Ager, J. Neo, and C. Christophi The renin-angiotensin system and malignancy Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684. [Abstract] [Full Text] [PDF]

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schachter, M. Search for Related Content PubMed PubMed Citation Articles by Schachter, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?